- Home
- KTF vs ZVRA Comparison
KTF vs ZVRA Comparison
Compare KTF & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTF
- ZVRA
- Stock Information
- Founded
- KTF 1988
- ZVRA 2006
- Country
- KTF United States
- ZVRA United States
- Employees
- KTF N/A
- ZVRA N/A
- Industry
- KTF Finance Companies
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- KTF Finance
- ZVRA Health Care
- Exchange
- KTF Nasdaq
- ZVRA Nasdaq
- Market Cap
- KTF 369.8M
- ZVRA 419.5M
- IPO Year
- KTF N/A
- ZVRA 2015
- Fundamental
- Price
- KTF $9.68
- ZVRA $7.69
- Analyst Decision
- KTF
- ZVRA Strong Buy
- Analyst Count
- KTF 0
- ZVRA 7
- Target Price
- KTF N/A
- ZVRA $21.20
- AVG Volume (30 Days)
- KTF 103.3K
- ZVRA 380.4K
- Earning Date
- KTF 01-01-0001
- ZVRA 03-27-2025
- Dividend Yield
- KTF 3.54%
- ZVRA N/A
- EPS Growth
- KTF N/A
- ZVRA N/A
- EPS
- KTF 0.39
- ZVRA N/A
- Revenue
- KTF N/A
- ZVRA $24,489,000.00
- Revenue This Year
- KTF N/A
- ZVRA N/A
- Revenue Next Year
- KTF N/A
- ZVRA $330.04
- P/E Ratio
- KTF $23.10
- ZVRA N/A
- Revenue Growth
- KTF N/A
- ZVRA 47.85
- 52 Week Low
- KTF $7.40
- ZVRA $4.20
- 52 Week High
- KTF $9.12
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- KTF 60.26
- ZVRA 48.77
- Support Level
- KTF $9.60
- ZVRA $7.64
- Resistance Level
- KTF $9.69
- ZVRA $8.21
- Average True Range (ATR)
- KTF 0.05
- ZVRA 0.29
- MACD
- KTF 0.01
- ZVRA 0.03
- Stochastic Oscillator
- KTF 91.67
- ZVRA 57.93
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-end, diversified investment management company. The investment objective is to provide high current income exempt from federal income tax by investing in a diversified portfolio of investment-grade tax-exempt securities. Its products include ETFs, Mutual Funds, Closed-End-Funds, Money Market Funds, and others.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.